FDA declines to regulate CBD; calls on Congress for fix
1 year, 10 months ago

FDA declines to regulate CBD; calls on Congress for fix

Associated Press  

The Food and Drug Administration said Thursday there are too many unknowns about CBD products to regulate them as foods or supplements under the agency’s current structure and called on Congress to create new rules for the massive and growing market. The marijuana-derived products have become increasingly popular in lotions, tinctures and foods, while their legal status has been murky in the U.S. There’s not enough evidence about CBD to confirm that it’s safe for use in foods or as a dietary supplement, FDA Deputy Commissioner Dr. Janet Woodcock said in a statement. “FDA has repeatedly disregarded evidence demonstrating safety that is relevant to CBD at the levels commonly used in supplements and continues to rely heavily on safety concerns related to high dosage Epidiolex to support the agency’s inaction,” Mister said in a statement. The FDA will continue to take action against CBD and other cannabis products to protect the public, Thursday’s statement said.

Discover Related